Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation

Eli Lilly · Phase 4 · Not yet recruiting · Enrollment 60

NCT07729332

ArmPopulationDoseWeeksEstimandWeight change
PhentermineObesity or overweightn/rn/rn/rn/r
OrforglipronObesity or overweightn/rn/rn/rn/r